A primer of amyloid nomenclature

Per Westermark, Merrill D. Benson, Joel N. Buxbaum, Alan S. Cohen, Blas Frangione, Shu Ichi Ikeda, Colin L. Masters, Giampaolo Merlini, Maria J. Saraiva, Jean D. Sipe

Research output: Contribution to journalArticle

243 Scopus citations


The increasing knowledge of the exact biochemical nature of the localized and systemic amyloid disorders has made a logical and easily understood nomenclature absolutely necessary. Such a nomenclature, biochemically based, has been used for several years but the current literature is still mixed up with many clinical and histochemically based designations from the time when amyloid in general was poorly understood. All amyloid types are today preferably named by their major fibril protein. This makes a simple and rational nomenclature for the increasing number of amyloid disorders known in humans and animals.

Original languageEnglish (US)
Pages (from-to)179-183
Number of pages5
Issue number3
StatePublished - 2007


  • Amyloid protein
  • Amyloidosis
  • Nomenclature

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Fingerprint Dive into the research topics of 'A primer of amyloid nomenclature'. Together they form a unique fingerprint.

  • Cite this

    Westermark, P., Benson, M. D., Buxbaum, J. N., Cohen, A. S., Frangione, B., Ikeda, S. I., Masters, C. L., Merlini, G., Saraiva, M. J., & Sipe, J. D. (2007). A primer of amyloid nomenclature. Amyloid, 14(3), 179-183. https://doi.org/10.1080/13506120701460923